Shifting patterns in the interpretation of phase III clinical trial outcomes in the treatment of advanced NSCLC.

6105 Background: Advanced non-small cell lung cancer (NSCLC) continues to have a grim prognosis despite decades of trials involving novel agents. Over time, there appears to be an increasing willin...